|
🐜
|
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
15 auth.
N. Galiè,
M. Humbert,
J. Vachiéry,
C. Vizza,
M. Kneussl,
A. Manes,
O. Sitbon,
A. Torbicki,
M. Delcroix,
R. Naeije,
...
M. Hoeper,
A. Chaouat,
S. Morand,
B. Besse,
G. Simonneau
|
9 |
2002 |
9
🐜
|
|
🐜
|
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
19 auth.
M. Hoeper,
T. Kramer,
Z. Pan,
C. Eichstaedt,
J. Spiesshoefer,
N. Benjamin,
K. Olsson,
K. Meyer,
C. Vizza,
A. Vonk-Noordegraaf,
...
O. Distler,
C. Opitz,
J. Gibbs,
M. Delcroix,
H. Ghofrani,
D. Huscher,
D. Pittrow,
S. Rosenkranz,
E. Grünig
|
9 |
2017 |
9
🐜
|
|
🐜
|
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.
28 auth.
M. Hoeper,
D. Huscher,
H. Ghofrani,
M. Delcroix,
O. Distler,
C. Schweiger,
E. Grunig,
G. Staehler,
S. Rosenkranz,
M. Halank,
M. Held,
C. Grohé,
T. Lange,
J. Behr,
H. Klose,
...
H. Wilkens,
A. Filusch,
Martin Germann,
R. Ewert,
H. Seyfarth,
K. Olsson,
C. Opitz,
S. Gaine,
C. Vizza,
A. Vonk-Noordegraaf,
H. Kaemmerer,
J. Gibbs,
D. Pittrow
|
8 |
2013 |
8
🐜
|
|
🦁
|
Right and left ventricular dysfunction in patients with severe pulmonary disease.
C. Vizza,
John P. Lynch,
Laura Ochoa,
Laura Ochoa,
Gregory Richardson,
E. Trulock
|
8 |
1998 |
8
🦁
|
|
🐜
|
Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
28 auth.
K. Olsson,
M. Delcroix,
H. Ghofrani,
H. Tiede,
D. Huscher,
R. Speich,
E. Grünig,
G. Staehler,
S. Rosenkranz,
M. Halank,
M. Held,
T. Lange,
J. Behr,
H. Klose,
M. Claussen,
...
R. Ewert,
C. Opitz,
C. Vizza,
L. Scelsi,
A. Vonk-Noordegraaf,
H. Kaemmerer,
J. Gibbs,
G. Coghlan,
J. Pepke-Zaba,
U. Schulz,
M. Gorenflo,
D. Pittrow,
M. Hoeper
|
8 |
2013 |
8
🐜
|
|
🐜
|
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
20 auth.
C. Opitz,
M. Hoeper,
J. Gibbs,
H. Kaemmerer,
J. Pepke-Zaba,
J. Coghlan,
L. Scelsi,
D. Michele,
Alto,
K. Olsson,
...
S. Ulrich,
W. Scholtz,
U. Schulz,
E. Grünig,
C. Vizza,
G. Staehler,
L. Bruch,
D. Huscher,
D. Pittrow,
S. Rosenkranz
|
8 |
2016 |
8
🐜
|
|
🐜
|
Prostanoid therapy for pulmonary arterial hypertension.
7 auth.
D. Badesch,
V. McLaughlin,
M. Delcroix,
C. Vizza,
H. Olschewski,
O. Sitbon,
...
R. Barst
|
7 |
2004 |
7
🐜
|
|
🐜
|
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
10 auth.
X. Jaïs,
K. Olsson,
J. Barberà,
I. Blanco,
A. Torbicki,
A. Peacock,
...
C. Vizza,
P. Macdonald,
M. Humbert,
M. Hoeper
|
7 |
2012 |
7
🐜
|
|
🐜
|
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
33 auth.
M. Hoeper,
C. Pausch,
K. Olsson,
D. Huscher,
D. Pittrow,
E. Grünig,
G. Staehler,
C. Vizza,
H. Gall,
O. Distler,
C. Opitz,
J. Gibbs,
M. Delcroix,
H. Ghofrani,
D. Park,
...
R. Ewert,
H. Kaemmerer,
H. Kabitz,
D. Skowasch,
J. Behr,
K. Milger,
M. Halank,
H. Wilkens,
H. Seyfarth,
M. Held,
D. Dumitrescu,
I. Tsangaris,
A. Vonk-Noordegraaf,
S. Ulrich,
H. Klose,
M. Claussen,
T. Lange,
S. Rosenkranz
|
7 |
2021 |
7
🐜
|
|
🐜
|
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy: A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
10 auth.
E. Giannetta,
A. Isidori,
N. Galea,
I. Carbone,
E. Mandosi,
C. Vizza,
...
F. Naro,
S. Morano,
F. Fedele,
A. Lenzi
|
7 |
2012 |
7
🐜
|
|
🐜
|
Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension–Targeted Therapy: The EURO-MR Study
14 auth.
A. Peacock,
Stephen F. Crawley,
L. E. R. McLure,
K. Blyth,
C. Vizza,
R. Poscia,
M. Francone,
I. Iacucci,
H. Olschewski,
G. Kovacs,
...
A. Vonk Noordegraaf,
J. Marcus,
M. C. van de Veerdonk,
F. Oosterveer
|
7 |
2014 |
7
🐜
|
